This updated edition explores biosimilar drugs' strategic planning, focusing on legal matters, patents, regulatory pathways, and global affordability. It examines the science, technology, finance, ethics, and politics of biosimilars while presenting strategies for development and lifecycle management.
We are registering your order now. Please stay on this page while we redirect you to the confirmation page.